ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JDM is an international journal dedicated to the current developments of Diabetes Mellitus, the broad scope will also include significant research in the fields of pathology and therapeutic innovations of diabetes itself, both type I and II. All manuscripts submitted to JDM must be previously unpublished and may not b…
Alfred Friday Ehiaghe, Dennis E. Agbonlahor, Youtchou Mirabeau Tatfeng, Folarin Onikepe, Faith Efosa Oviasogie, Joy Imuetinya Ehiaghe
C reactive protein is sensitive physiological biomarkers of sub clinical inflammation associated with hyperglycemia. The aim of this study is to determine the fasting serum C reactive protein level in type 2 diabetes mellitus patients attending diabetic clini…
Hiroyuki Ito, Mariko Abe, Masahiro Shinozaki, Takashi Omoto, Shinya Nishio, Masahide Furusho, Shinichi Antoku, Mizuo Mifune, Michiko Togane, Tsutomu Sanaka
Aims: The associations between the number of antihypertensive agents being taken by type 2 diabetic patients and 1) the grade of atherosclerosis according to non-invasive surrogate markers for atherosclerosis and 2) the other risk factor for atherosclerosis,…
Stefano Benedini, Andrea Caumo, leana Terruzzi, Livio Luzi
Diabetes mellitus is a metabolic disease possible to treat via pancreas/islet transplantation but most immunosuppressive drugs are diabetogenic. In this letter, we review current up to date methods to assess insulin action and secretion (using the surrogate i…
Supattra Srivanichakorn, Tassanee Yana, Pattara Sanchaisuriya, Yu Yu Maw, Frank Peter Schelp
Background: A dataset from a nationwide assessment of type 2 diabetes mellitus (T2DM) patients fromThailandwas reassessed. Objective: Prevalence of T2DM is highest in the northeast ofThailandand the intention of the study was to assess whether the clinical pi…
Nevi Pasko, Florian Toti, Ervin Zekollari, Arjana Strakosha, Viola Kacori, Nestor Thereska
Background: Microalbuminuria is often the first sign of renal involvement predicting overt nephropathy. For this reason, monitoring microalbuminuria and other risk factors associated with this condition is important to take measures to prevent or postpone ove…
Pat Rapley, Gwen Babel, Joey Kaye, Suzanne Brown
Aim: To explore family responsibility dynamics, metabolic control, clinic attendance, and emergency admis sions when young adults (YA) with type 1 diabetes transition to an adult hospital. Method: A longitudinal mixed method design with two study groups (pare…
Allen Mark Jacobs, Dunlei Cheng
Objective: To study the effect of addition of Metanx on burning parasthesias in patients with symptomatic diabetic neuropathy who had obtained only partial symptom resolution with pregabalin. Research design and methods: This was an open-label pilot study. Th…
Udaya M. Kabadi
Background: Several recent studies have shown that treatment with therapeutic lifestyle changes, and/or several drugs retard progression of prediabetes to type 2 diabetes. However, none of these studies used a Sulfonylurea (SU), although in UKPDS, SUs delayed…
Hua Su, Xingyan Liu, Ling Su, Li Zhang, Xiangguo Liu, Hong Ji, Haiqin Rong
Glibenclamide, a blocker of ATP-sensitive potassium channels, has been found to induce apoptosis in some cell types, including pancreatic beta-cells. Since autophagy plays doubleedged roles in pancreatic beta-cell survival, frequently through cross-talking wi…
Selestin Dongmo Sokeng, Begum Rokeya, Jamadder Mohammed Abdul Hannan, Liaquat Ali, Pierre Kamtchouing
Backgroung: Bridelia ndellensis (Euphorbiaceae) is used as a traditional plant treatment of diabetes. The aim of the present study was to investigate the mechanism involved in the antihyperglycemic effects of this plant. Methods: An intestinal perfusion techn…
No articles in this issue.
JDM is an international journal dedicated to the current developments of Diabetes Mellitus, the broad scope will also include significant research in the fields of pathology and therapeutic innovations of diabetes itself, both type I and II. All manuscripts submitted to JDM must be previously unpublished and may not b… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).